Ultragenyx Pharmaceutical Inc (RARE)

May 14, 2025

Ultragenyx Underscores Continued Commitment to Rare Disease Inno - GuruFocus

May 14, 2025

May 14, 2025

Ultragenyx Underscores Continued Commitment to Rare Disease Innovation with 2024 Impact Report | RARE Stock News - GuruFocus

May 14, 2025

May 14, 2025

Ultragenyx Underscores Continued Commitment to Rare Disease Innovation with 2024 Impact Report - GlobeNewswire

May 14, 2025

May 14, 2025

(RARE) Technical Pivots with Risk Controls - news.stocktradersdaily.com

May 14, 2025

May 13, 2025

Transcript : Ultragenyx Pharmaceutical Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com

May 13, 2025

May 12, 2025

Glycogen Storage Disease Treatment Market Size in 7MM - openPR.com

May 12, 2025

May 09, 2025

RARE: Morgan Stanley Raises Price Target for Ultragenyx Pharmace - GuruFocus

May 09, 2025

May 09, 2025

Q1 S&E In Brief: Tracking New Launches And Catalysts In Biopharma - insights.citeline.com

May 09, 2025

May 09, 2025

RARE: Morgan Stanley Raises Price Target for Ultragenyx Pharmaceutical | RARE Stock News - GuruFocus

May 09, 2025

May 09, 2025

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st

May 09, 2025

May 09, 2025

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - Yahoo Finance

May 09, 2025

May 09, 2025

Ultragenyx's Q1 Loss Wider Than Expected, Revenues Increase Y/Y - MSN

May 09, 2025

May 09, 2025

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2025 Earnings Call Transcript - Insider Monkey

May 09, 2025

May 08, 2025

Ultragenyx to Participate at Bank of America's 2025 Healthcare C - GuruFocus

May 08, 2025

May 08, 2025

Ultragenyx price target lowered to $100 from $140 at Truist - Yahoo Finance

May 08, 2025

May 08, 2025

Shareholders Will Probably Hold Off On Increasing Ultragenyx Pharmaceutical Inc.'s (NASDAQ:RARE) CEO Compensation For The Time Being - simplywall.st

May 08, 2025

May 08, 2025

Truist Financial Remains a Buy on Ultragenyx Pharmaceutical (RARE) - The Globe and Mail

May 08, 2025

May 08, 2025

Ultragenyx Pharmaceutical First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

May 08, 2025

May 08, 2025

Decoding Ultragenyx Pharmaceutical Inc (RARE): A Strategic SWOT Insight - GuruFocus

May 08, 2025

May 07, 2025

Ultragenyx Reports Strong Growth Amid Challenges - TipRanks

May 07, 2025

May 07, 2025

Ultragenyx to Participate at Bank of America’s 2025 Healthcare Conference - GlobeNewswire

May 07, 2025

May 07, 2025

Ultragenyx projects $640M-$670M revenue for 2025 with strong product growth - MSN

May 07, 2025

May 07, 2025

Ultragenyx (RARE) Sees Price Target Reduced Amid Gene Therapy Outlook | RARE Stock News - GuruFocus

May 07, 2025

May 07, 2025

Ultragenyx (RARE) Stock: Citi Recommends Buy Amidst Valuation In - GuruFocus

May 07, 2025

May 07, 2025

Ultragenyx (RARE) Stock: Citi Recommends Buy Amidst Valuation Insights | RARE Stock News - GuruFocus

May 07, 2025

May 07, 2025

Ultragenyx Pharmaceutical Q1 2025 Earnings Call Transcript - MarketBeat

May 07, 2025

May 07, 2025

Ultragenyx Pharmaceutical Inc (RARE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance

May 07, 2025

May 07, 2025

Ultragenyx Pharmaceutical Inc (RARE) Q1 2025 Earnings Call Highl - GuruFocus

May 07, 2025

May 07, 2025

Ultragenyx Pharmaceutical Inc (RARE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... By GuruFocus - Investing.com Canada

May 07, 2025

May 07, 2025

Ultragenyx: Q1 Earnings Snapshot - CTPost

May 07, 2025

May 07, 2025

Ultragenyx Reports Strong Q1 2025 Revenue Growth - TipRanks

May 07, 2025

May 07, 2025

Ultragenyx (RARE) Reports Strong Q1 2025 Revenue Growth Driven b - GuruFocus

May 07, 2025

May 06, 2025

Ultragenyx (RARE) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance

May 06, 2025

May 06, 2025

Ultragenyx misses Q1 estimates, shares fall on weak results By Investing.com - Investing.com Canada

May 06, 2025

May 06, 2025

Ultragenyx misses Q1 estimates, shares fall on weak results - Investing.com

May 06, 2025

May 06, 2025

Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

May 06, 2025

May 06, 2025

Ultragenyx (RARE) Reports Q1 Revenue Below Expectations | RARE S - GuruFocus

May 06, 2025

May 06, 2025

Ultragenyx Pharmaceutical Inc Reports Q1 2025 Earnings: EPS of -$1.57 Beats Estimates, Revenue of $139 Million Misses Expectations - GuruFocus

May 06, 2025

May 06, 2025

Ultragenyx Pharmaceutical Q1 Loss Narrows - Nasdaq

May 06, 2025

May 06, 2025

Ultragenyx (RARE) Reaffirms FY25 Financial Outlook with Positive Revenue Growth | RARE Stock News - GuruFocus

May 06, 2025

May 06, 2025

Ultragenyx Reports First Quarter 2025 Financial Results and Corporate Update - The Manila Times

May 06, 2025

May 06, 2025

Ultragenyx May 2025 slides: pipeline advances driving path to profitability - Investing.com

May 06, 2025

May 06, 2025

Ultragenyx May 2025 slides: pipeline advances driving path to profitability By Investing.com - Investing.com South Africa

May 06, 2025

May 06, 2025

X-linked Hypophosphatemia Market 2025-2032 Business Outlook, - openPR.com

May 06, 2025

May 05, 2025

Ultragenyx Pharmaceutical's Earnings: A Preview - Nasdaq

May 05, 2025

May 05, 2025

5 Drug/Biotech Stocks Likely to Outperform Q1 Earnings Estimates - TradingView

May 05, 2025

May 02, 2025

Ultragenyx Pharmaceutical Inc expected to post a loss of $1.61 a shareEarnings Preview - TradingView

May 02, 2025

May 01, 2025

US FDA Not Industry’s ‘Sock Puppet,’ Ultragenyx’s Emil Kakkis Says - insights.citeline.com

May 01, 2025

Apr 30, 2025

BlackRock, Inc. Reduces Stake in Ultragenyx Pharmaceutical Inc. - GuruFocus

Apr 30, 2025

Apr 30, 2025

Ultragenyx to Host Conference Call for First Quarter 2025 Financ - GuruFocus

Apr 30, 2025